Discover our

Services for Media

A person's finger touches a screen.

Are you a media representative looking for content on Bayer? This section provides news, press photos and more.

News
August 24, 2026
Not intended for U.S. and UK Media

Bayer’s sevabertinib approved in Japan for patients with HER2-mutant non-small cell lung cancer

August 13, 2026
Not intended for U.S. and UK Media

Aflibercept 8 mg application for macular edema following retinal vein occlusion accepted for review in China

August 04, 2026
Second quarter of 2026:

Bayer operationally on track, decisive progress on strategic priorities

NEWS OVERVIEW